Delivery Order SPE2DB22D2006-SPE2DB25FV8BA

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a prescription medication. The contract has a ceiling value of $2,680.50 and a period of performance through January 7, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,325.53 firm fixed-price contract is for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product, with a ceiling value of $1,256.40 and an ultimate completion date of June 17, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,587.45, is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S medication. This is a firm fixed-price contract with an ultimate completion date of January 6, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,281.24 firm fixed price contract is for the delivery of RYTARY ER 23.75 MG-95 MG capsules. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA Troop Support Medical) to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,087.98 and a performance period ending on March 12, 2024. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription pharmaceutical product. No set-aside designation was used for this...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a specialty medication. The contract has a ceiling value of $2,142.00 and a completion date of August 6, 2024. It is a firm-fixed-price contract, indicating a set price for the delivered items. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $9,176.93 award is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. This delivery order falls under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, to provide a broad range of...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of RYTARY ER 23.75 MG-95 MG CAP 100S, a pharmaceutical product, with a potential value of $12,115.00 and a period of performance through March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a delivery order worth $3,303.00 for RYTARY ER 61.25 MG-245 MG CAP 100S. The award was made by the Defense Logistics Agency (DLA), a defense agency, under an Indefinite Delivery Contract (IDC) that has a ceiling value of $999,999,999 and runs through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8BA
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,761.74, is for the delivery of 4567117581 RYTARY ER 48.75 MG-195 MG capsules in lots of 100. The contract is a Firm Fixed Price type, with a period of performance through February 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific order does not have a set-aside designation, indicating open competition.

Generated 5/2/25, 9:55 AM